New data visualisations and statistics on measles and human papillomavirus (HPV)
CHMP recommends 16 new medicines for approval in the EU
Medicines Shortages Steering Group (MSSG) recommends strengthening Europe’s production capacity
Public consultation open until end September 2025
Seizing opportunities in a changing medicines landscape
Find medicine
What's new
FAQs
Latest news
Consultation of the Board constitutes first step of renewal process
Duvyzat can be used in a wide patient population from the age of six
16 new medicines recommended for approval; another ten medicines recommended for extension of their therapeutic indications
Tepezza significantly improves symptoms for patients with moderate-to-severe TED
EMA and HMA encourage strengthening Europe’s production capacity
Outcomes of the Committee for Veterinary Medicinal Products (CVMP) meeting
Information for you
Patients and carers
Healthcare professionals
Animal health professionals
Pharmaceutical Industry
Media
